Basic info
Industry
pharmaceuticals
Sectors
Biotechnology
Process Development
Protein Biochemistry and Therapeutics
Microbial and Mammalian Gene Expression
Microbiology
Biophysical Characterization
Protein and mAb Engineering
Antibody Display Technology
Formulation Development
Surface Plasmon Resonance/Biacore Analysis
Analytical Chemistry
Assay Development and Validation
Intrinsic Florescence Analysis
Cell Based Assays and Screening
Preclinical Trial Material Manufacturing
Pharmaceutical
including humanization
mAb Based Discovery
Diagnostic Development Support
Characterization of Hybridomas
Over the Counter Product Development and Licensing
Medical
Monoclonal Antibodies Derived From Murine Models
Stability Programs
Date founded
2017
Funding rounds raised
Total raised
$65M
from 5 investors over 5 rounds
P
PMI BioPharma Solutions LLC raised $65M on December 1, 2022
Investors: Polaris Partners and Oak HC/FT
P
PMI BioPharma Solutions LLC raised $24M on May 27, 2021
Investors: Polaris Partners and Oak HC/FT
P
PMI BioPharma Solutions LLC raised undisclosed on July 16, 2020
Investors: Oak HC/FT